Search / Trial NCT06225154

Effect of Periodontal Treatment on Adipokine Levels

Launched by MARMARA UNIVERSITY · Jan 16, 2024

Trial Information

Current as of October 07, 2024

Completed

Keywords

Adipokines Diabetes Mellitus Inflammation Periodontitis

Description

The present study aimed to determine the effect of non-surgical periodontal treatment (NSPT) on serum and salivary adipokine and interleukin (IL)-1β levels in periodontitis patients with or without type 2 Diabetes Mellitus (T2DM). A total of 80 patients; 20 healthy, 20 T2DM with periodontitis (P), 20 T2DM periodontally healthy, 20 systemically healthy with P were included in this study. At baseline, serum and saliva samples were collected and the whole mouth clinical periodontal parameters were recorded. Periodontitis patients received NSPT in 4 sessions. Clinical parameters were re-measure...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Diabetes mellitus should be diagnosed for ≥1 year and HbA1c level should be at least %6,5
  • * Periodontitis should be diagnosed for at least 4 teeth with probing depth ≥5 mm with bleeding on probing (BOP) and also radiographic alveolar bone loss should be presence
  • * Presence of at least 15 teeth
  • Exclusion Criteria:
  • * Received antibiotic treatment in the previous 3 months
  • * Smokers
  • * Pregnancy and lactation
  • * Received periodontal treatment in the previous 6 months
  • * Presence of less than 15 teeth
  • * Having major diabetic complications

About Marmara University

Marmara University is a distinguished academic institution located in Istanbul, Turkey, renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust infrastructure and a multidisciplinary approach, the university actively engages in the development and evaluation of new therapeutic interventions, fostering collaboration among researchers, clinicians, and industry partners. Marmara University’s focus on ethical standards and patient safety underscores its dedication to contributing valuable insights to the medical community and improving health outcomes.

Locations

Turku, Lemminkäisenkatu 2, Finland

İstanbul, Maltepe, Turkey

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0